Alerts will be sent to your verified email
Verify Email
INNOVACAP
|
Innova Captab
|
Hikal
|
Supriya Lifescience
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
23.11 % | 10.48 % | 29.47 % |
|
5yr average Equity Multiplier
|
2.47 | 2.17 | 1.48 |
|
5yr Average Asset Turnover Ratio
|
1.17 | 0.81 | 0.74 |
|
5yr Avg Net Profit Margin
|
7.98 % | 5.87 % | 24.83 % |
|
Price to Book
|
5.84 | 4.27 | 6.28 |
|
P/E
|
41.03 | 68.88 | 32.6 |
|
5yr Avg Cash Conversion Cycle
|
30.74 Days | 33.87 Days | 10.2 Days |
|
Inventory Days
|
52.35 Days | 64.21 Days | 54.74 Days |
|
Days Receivable
|
93.25 Days | 101.46 Days | 55.39 Days |
|
Days Payable
|
105.4 Days | 96.57 Days | 115.12 Days |
|
5yr Average Interest Coverage Ratio
|
10.13 | 4.8 | 36.33 |
|
5yr Avg ROCE
|
25.9 % | 13.73 % | 37.03 % |
|
5yr Avg Operating Profit Margin
|
13.09 % | 16.42 % | 34.97 % |
|
5 yr average Debt to Equity
|
0.58 | 0.68 | 0.17 |
|
5yr CAGR Net Profit
|
27.62 % | -3.79 % | 10.17 % |
|
5yr Average Return on Assets
|
9.22 % | 4.82 % | 18.81 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.9 % | 68.85 % | 68.3 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.08 % | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
7.35 % | 2.17 % | -2.68 % |
|
Innova Captab
|
Hikal
|
Supriya Lifescience
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|